You are browsing content specific to your location, some treatments may not be available:

Endometrial Receptivity Analysis (ERA)

Endometrial Receptivity Analysis (ERA) is a test to assess the endometrial status and determine the presence of a receptive gene profile in the patient's endometrium during the biopsy.

The human endometrium is a highly dynamic tissue that is capable of undergoing physiological changes in response to steroid hormones. Thus, it creates a receptive status that is synchronized with the arrival of an implanting blastocyst (refers to an embryo that is 5 days old after successful fertilization).

Who should consider ERA?

The ERA is considered in women who:
•    Experienced multiple implantation failures with embryo transfers despite good quality of the embryos
•    Undergone 3 or more failures and younger than 35 years
•    Had 3 failures and older than 35 years

What is Endometrial Receptivity Genome Analysis?

Endometrial Receptivity Genome Analysis is a state-of-the-art diagnostic method. This test evaluates the endometrial receptivity status from a molecular point of view. It helps to assess the receptivity for endometrium for implantation by analyzing the expression of a group of genes related to endometrial receptivity

Types of treatment related to this article

In Vitro Fertilization (IVF)

IVF means in vitro fertilization.  In vitro means in the laboratory ( outside the body)  and fertilization refers to conception (joining of a woman’s egg and a

Learn More


PGT-SR is a genetic test for detecting inherited chromosomal structural rearrangements in embryos prior to their transfer and enhancing the chance of a

Learn More


Preimplantation genetic testing for a monogenic gene (PGT‐M) is formerly known as Preimplantation genetic diagnosis (PGD).  PGT-M is a diagnostic tool for

Learn More

We are here to help